logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > Chemical Intermediates > Lornoxicam CAS 70374-39-9

Lornoxicam CAS 70374-39-9

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 70374-39-9

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Bag,Drum

Delivery Time: 7-15 days

Payment Terms: L/C, D/A, T/T, Western Union

Supply Ability: TON

Get Best Price
Highlight:
CAS NO::
70374-39-9
Appearance::
Crystalline Solid
Molecular Formula::
C13H10ClN3O4S2
Molecular Weight::
371.81900
EINECS NO::
630-354-7
MDL NO::
MFCD00866163
CAS NO::
70374-39-9
Appearance::
Crystalline Solid
Molecular Formula::
C13H10ClN3O4S2
Molecular Weight::
371.81900
EINECS NO::
630-354-7
MDL NO::
MFCD00866163
Lornoxicam CAS 70374-39-9

Product Description:

Product Name: Lornoxicam CAS NO: 70374-39-9

 

 

Synonyms:

6-chloro-4-hydroxy-2-methyl-1,1-dioxo-N-pyridin-2-ylthieno[2,3-e]thiazine-3-carboxamide;

 

 

Chemical & Physical Properties:

Appearance: Crystalline Solid

Assay :≥99.00%

Density: 1.727g/cm3

Melting Point: 225-230℃ (dec.)

Refractive Index: 1.741

Storage Condition: -20℃ Freezer

 

 

Safety Information:

Safety Statements: S26; S36

HS Code: 2934999090

Risk Statements: R36/37/38

Hazard Code: Xi

 

 

Cyclooxygenase inhibitor; structurally similar to Tenoxicam. Anti-inflammatory; analgesic. Lornoxicam (Trade name: “Xefo”) belongs to a non-steroidal anti-inflammatory drug. As a kind of oxicam class drug, it has analgesic, anti-inflammatory and antipyretic properties. It can be used for the treatment of various type of acute mild to moderate pain which results from inflammatory diseases of the joints, osteoarthritis, surgery, sciatica and rheumatic diseases. Lornoxicam is capable of potently inhibiting the prostaglandin biosynthesis process, making it have highly pronounced efficacy. The exact mechanism of Lornoxicam is not exactly understood. However, it is indicated that Lornoxicam can inhibit the prostaglandin and thromboxane synthesis by inhibiting both COX-1 and COX-2, leading to reduction of inflammation, pain, fever, and swelling. For the treatment of acute mild to moderate pain, as well as pain and inflammation of the joints caused by certain types of rheumatic diseases.

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.